# ![@LegendBiotech Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1118313393256005632.png) @LegendBiotech Legend Biotech

Legend Biotech posts on X about ceo, data, longterm, future the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::1118313393256005632/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1118313393256005632/c:line/m:interactions.svg)

- [--] Week [---] -26%
- [--] Month [-----] +191%
- [--] Months [-----] -29%
- [--] Year [------] +153%

### Mentions: [--] [#](/creator/twitter::1118313393256005632/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1118313393256005632/c:line/m:posts_active.svg)

- [--] Month [--] -58%
- [--] Months [--] -3.60%
- [--] Year [--] +208%

### Followers: [-----] [#](/creator/twitter::1118313393256005632/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1118313393256005632/c:line/m:followers.svg)

- [--] Week [-----] +0.46%
- [--] Month [-----] +2.50%
- [--] Months [-----] +2.80%
- [--] Year [-----] +9%

### CreatorRank: [---------] [#](/creator/twitter::1118313393256005632/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1118313393256005632/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [countries](/list/countries)  [travel destinations](/list/travel-destinations)  [technology brands](/list/technology-brands) 

**Social topic influence**
[ceo](/topic/ceo), [data](/topic/data), [longterm](/topic/longterm), [future](/topic/future), [global](/topic/global), [$legn](/topic/$legn) #8, [belgium](/topic/belgium), [science](/topic/science), [cell](/topic/cell) #131, [in the](/topic/in-the)

**Top accounts mentioned or mentioned by**
[@asco](/creator/undefined) [@astct](/creator/undefined) [@cibmtr](/creator/undefined) [@ashhematology](/creator/undefined) [@biotechtv](/creator/undefined) [@myelomasociety](/creator/undefined) [@jpmorgan](/creator/undefined) [@imfmyeloma](/creator/undefined) [@genbio](/creator/undefined) [@morganstanley](/creator/undefined) [@thelancetoncol](/creator/undefined) [@ehahematology](/creator/undefined) [@yinghuang](/creator/undefined) [@bradloncar](/creator/undefined) [@popscis](/creator/undefined) [@societyofhemonc](/creator/undefined) [@chihealthtech](/creator/undefined) [@komoptgkanker](/creator/undefined) [@pharmascrip](/creator/undefined) [@penn](/creator/undefined)

**Top assets mentioned**
[Legend Biotech Corp (LEGN)](/topic/$legn) [Morgan Stanley (MS)](/topic/morgan-stanley)
### Top Social Posts
Top posts by engagements in the last [--] hours

"We're excited to be at the 21st Annual Morgan Stanley Global Healthcare Conference where representatives from our executive management team have been representing the company. See you there. #MorganStanley #biotech #biopharma"  
[X Link](https://x.com/LegendBiotech/status/1701629794843009461)  2023-09-12T16:12Z [---] followers, [--] engagements


"On "#HispanicHeritageMonth we honor the contributions of Hispanic/Latinx people to our home state of New Jersey"  
[X Link](https://x.com/LegendBiotech/status/1702661073545969776)  2023-09-15T12:30Z [---] followers, [--] engagements


"We're excited to attend the @myeloma_society [----] annual meeting and showcase the latest data from the CARTITUDE Development Program in #MultipleMyeloma: #IMS2023 #BloodCancer"  
[X Link](https://x.com/LegendBiotech/status/1707009723675894060)  2023-09-27T12:30Z [---] followers, [---] engagements


"We're looking forward to this year's #MeetingontheMesa where we can connect with our peers in #cgtherapy. Will we see you in Carlsbad CA #celltherapy"  
[X Link](https://x.com/LegendBiotech/status/1707777707159810425)  2023-09-29T15:21Z [----] followers, [---] engagements


"Currently there are [--] FDA-approved CAR-T cell therapies. Tune into a discussion between our head of Commercial Development in the US/EU Steve Gavel and industry peers as they discuss how and when one size fits all in #cellandgene--and when it doesn't"  
[X Link](https://x.com/LegendBiotech/status/1709184064299696462)  2023-10-03T12:30Z [---] followers, [--] engagements


"Our Quality Organization helps ensure that the products we deliver to patients are safe each and every time. Hear from our global head of Quality Alan Kick on what it takes to get there. #NHQW #NationalHealthQualityWeek"  
[X Link](https://x.com/LegendBiotech/status/1713895090484052440)  2023-10-16T12:30Z [---] followers, [---] engagements


"In addition to deep expertise in CAR-T we are also exploring CAR gamma-delta-T. "Every day we come closer to harnessing these cells" says Sophia Zhang a leader in our Discovery Research team. Learn more:"  
[X Link](https://x.com/LegendBiotech/status/1714671788792455560)  2023-10-18T15:56Z [---] followers, [--] engagements


"Will you be attending the #CHIBioprocessingSummit Europe in Barcelona Spain Our Sr. Director of CAR-T Operations Sarah Snykers will be speaking at the @CHI_Healthtech Bioprocessing Summit on March [--] at 4:20 p.m. CET. See you there Learn more:"  
[X Link](https://x.com/LegendBiotech/status/1768285780491829662)  2024-03-14T14:39Z [---] followers, [--] engagements


"Members of our team in Belgium recently participated in the @komop_tgkanker cycling challenge benefitting cancer research. Our LEGENDs trained hard to cycle 1000km from May 9-12. Congratulations to the team for this amazing feat #WeAreLegend #KomOpTegenKanker #de1000km"  
[X Link](https://x.com/LegendBiotech/status/1790799055246774428)  2024-05-15T17:39Z [---] followers, [--] engagements


"Our CEO Ying Huang recently sat down with @PharmaScrip to discuss our #MultipleMyeloma data and shed light on our pilot program with @Penn which aims to expand the reach of our #CART therapy. Read the article here: #ASCO24 https://bit.ly/3RcZ5gi https://bit.ly/3RcZ5gi"  
[X Link](https://x.com/LegendBiotech/status/1799128566287753334)  2024-06-07T17:17Z [---] followers, [--] engagements


"#LegendNews: Today we released our [----] second-quarter financial results and Jessie Yeung Vice President of Investor Relations & Finance shares her thoughts. Read the full report: #CellTherapy https://www.globenewswire.com/en/news-release/2024/08/09/2927688/0/en/Legend-Biotech-Reports-Second-Quarter-2024-Results-and-Recent-Highlights.html https://www.globenewswire.com/en/news-release/2024/08/09/2927688/0/en/Legend-Biotech-Reports-Second-Quarter-2024-Results-and-Recent-Highlights.html"  
[X Link](https://x.com/LegendBiotech/status/1821865329615626375)  2024-08-09T11:05Z [----] followers, [---] engagements


"Are you attending @Phacilitates #ATE24 in Lisbon Portugal Our MS&T Process Engineering & Validation Senior Manager Emilie Kleiren will participate in a discussion about revolutionizing #CellTherapy on September [--] at 2:00 p.m. See you there #AdvancedTherapies"  
[X Link](https://x.com/LegendBiotech/status/1833593988756185117)  2024-09-10T19:50Z [----] followers, [---] engagements


"#LegendNews: Our cutting-edge Obelisc facility in Ghent Belgium has officially initiated commercial production of our #CellTherapy. We are laser-focused on increasing our production capacity to meet the needs of patients with #MultipleMyeloma around the world"  
[X Link](https://x.com/LegendBiotech/status/1847320989186592803)  2024-10-18T16:57Z [----] followers, [---] engagements


"#LegendNews: Legend Biotech will host a webcast to announce [----] third-quarter financial results on November [--] at [--] a.m. ET. Register to join here: https://www.globenewswire.com/en/news-release/2024/10/24/2968663/0/en/Legend-Biotech-to-Host-Investor-Conference-Call-on-Third-Quarter-2024-Results.html https://www.globenewswire.com/en/news-release/2024/10/24/2968663/0/en/Legend-Biotech-to-Host-Investor-Conference-Call-on-Third-Quarter-2024-Results.html"  
[X Link](https://x.com/LegendBiotech/status/1849422533591769279)  2024-10-24T12:07Z [----] followers, [---] engagements


"#LegendNews: We're thrilled to announce Alan Bash as the newest member of our executive team. We welcome his experience as we strengthen our position in the #MultipleMyeloma treatment paradigm and drive the companys growth of our #CellTherapy. Read more: https://www.globenewswire.com/en/news-release/2024/11/04/2973951/0/en/Legend-Biotech-Appoints-Alan-Bash-as-President-of-CARVYKTI.html https://www.globenewswire.com/en/news-release/2024/11/04/2973951/0/en/Legend-Biotech-Appoints-Alan-Bash-as-President-of-CARVYKTI.html"  
[X Link](https://x.com/LegendBiotech/status/1853417140189106441)  2024-11-04T12:40Z [----] followers, [---] engagements


"#LegendNews: Well be onsite for @ASH_hematologys Annual Meeting to present data on minimal residual disease negativity rates from our Phase [--] #MultipleMyeloma study. Visit exhibit booth #2805 to learn more about our oral and poster presentations #ASH24 https://www.globenewswire.com/en/news-release/2024/11/05/2975002/0/en/Legend-Biotech-to-Unveil-Minimal-Residual-Disease-Data-from-Landmark-CARTITUDE-4-Trial-in-Multiple-Myeloma.html"  
[X Link](https://x.com/LegendBiotech/status/1853805686959882719)  2024-11-05T14:24Z [----] followers, [---] engagements


"#LegendNews: Legend Biotech will host an investor event on Sunday December [--] at 8:00 PT during the 66th @ASH_hematology Annual Meeting and Exposition in San Diego Register here to access the live webcast: #ASH24 #Investors #CellTherapy https://www.globenewswire.com/en/news-release/2024/11/07/2976570/0/en/Legend-Biotech-to-Host-Investor-Event-During-the-66th-American-Society-of-Hematology-ASH-Annual-Meeting-and-Exposition.html"  
[X Link](https://x.com/LegendBiotech/status/1854502733165838648)  2024-11-07T12:34Z [----] followers, [---] engagements


"Legend Biotech and our partners at @JanssenUS attended the [----] #PrixGalien USA Awards last week where our #CellTherapy was nominated for Best Biotechnology Product. Thanks to @GalienFdn for its ongoing commitment to scientific innovation. #WeAreLegend"  
[X Link](https://x.com/LegendBiotech/status/1855981474140266564)  2024-11-11T14:30Z [----] followers, [---] engagements


"#LegendNews: Today we released our [----] third-quarter financial results. Our CEO Ying Huang shares his thoughts. Read the highlights here: #CellTherapy #CART https://www.globenewswire.com/en/news-release/2024/11/12/2978897/0/en/Legend-Biotech-Reports-Third-Quarter-2024-Results-and-Recent-Highlights.html https://www.globenewswire.com/en/news-release/2024/11/12/2978897/0/en/Legend-Biotech-Reports-Third-Quarter-2024-Results-and-Recent-Highlights.html"  
[X Link](https://x.com/LegendBiotech/status/1856307468332138671)  2024-11-12T12:06Z [----] followers, [---] engagements


"The @APSHOorgs [----] @JADPRO Live exhibit opens today If youre attending stop by our booth (#1016) to chat with our team and learn more about #CellTherapy for #MultipleMyeloma. See you there #JADPROLive #Oncology #Hematology"  
[X Link](https://x.com/LegendBiotech/status/1857487761705676886)  2024-11-15T18:16Z [----] followers, [---] engagements


"We are heading to the @ASH_hematology Annual Meeting this weekend Dont miss our oral presentation on MRD negativity rates and poster presentations. Be sure to stop by our exhibit at #2805. We look forward to reconnecting with many of our friends and colleagues #ASH24"  
[X Link](https://x.com/LegendBiotech/status/1864671067257635177)  2024-12-05T14:00Z [----] followers, [---] engagements


"#LegendNews: We're presenting new findings from our Phase [--] study at the @ASH_hematology Annual Meeting & Exposition. Our latest data on MRD negativity rates reinforces the strength of our research for #MultipleMyeloma. Learn more: #ASH24 https://bit.ly/3BmRJSw https://bit.ly/3BmRJSw"  
[X Link](https://x.com/LegendBiotech/status/1866284550680088579)  2024-12-10T00:51Z [----] followers, [---] engagements


"Our team had a wonderful time at the @ASH_hematology Annual Meeting. It was a privilege to reconnect with the hematology community and those who participated in our live webcast investor event. Were committed to advancing CAR-T as a leading treatment option for cancer. #ASH24"  
[X Link](https://x.com/LegendBiotech/status/1866912949886922976)  2024-12-11T18:28Z [----] followers, [---] engagements


"Mark your calendars Our CEO Ying Huang will share Legend Biotechs latest updates at the @JPMorgan Healthcare Conference on January [--] [----] at 3:45 p.m. PT. Learn more and register: #JPMorganHealthcare #CellTherapy #JPMHC2025 https://www.globenewswire.com/news-release/2024/12/19/2999821/0/en/Legend-Biotech-to-Present-at-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html https://www.globenewswire.com/news-release/2024/12/19/2999821/0/en/Legend-Biotech-to-Present-at-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html"  
[X Link](https://x.com/LegendBiotech/status/1869731017738912200)  2024-12-19T13:06Z [----] followers, [---] engagements


"After a year of achieving significant milestones our LEGENDary team toasted our successes for patients and celebrated in seasonal attire to mark the holidays. We are grateful to all our employees for their dedication to the patients we serve each day. #WeAreLegend"  
[X Link](https://x.com/LegendBiotech/status/1870161228233904319)  2024-12-20T17:35Z [----] followers, [---] engagements


"Our CEO Ying Huang reflects on the past years successes and shares our ambitions for [----] and beyond. #WeAreLegend"  
[X Link](https://x.com/LegendBiotech/status/1873730763977543688)  2024-12-30T14:00Z [----] followers, [---] engagements


"At Legend Biotech we are laser-focused on transforming the future of cancer treatment. From our state-of-the-art Obelisc facility in Ghent we are developing personalized therapies that offer hope to #MutlitpleMyeloma patients. @tijd: https://bit.ly/4gTZGgY https://bit.ly/4gTZGgY"  
[X Link](https://x.com/LegendBiotech/status/1874921707296948700)  2025-01-02T20:52Z [----] followers, [---] engagements


"$LEGNs CEO Ying Huang will share Legend Biotechs latest updates during the @jpmorgan Healthcare Conference tomorrow January [--] @ 3:45 p.m. PT. Register for the live audio webcast: #JPMorganHealthcare #JPM25 #CellTherapy https://bit.ly/LEGNJPM https://bit.ly/LEGNJPM"  
[X Link](https://x.com/LegendBiotech/status/1878821976636334274)  2025-01-13T15:10Z [----] followers, [---] engagements


"Attending #ATW25 Dont miss our Senior Director of CAR-T Operations Sarah Snykers PhD session tomorrow at 12:15 pm Theater [--] where she will share insights from our rapid expansion of CAR-T production in Ghent Belgium highlighting key learnings from this experience. $LEGN"  
[X Link](https://x.com/LegendBiotech/status/1881325810235179383)  2025-01-20T13:00Z [----] followers, [---] engagements


"What a fantastic time ringing in the New Year with our team in Ghent We toasted the hard work dedication and collaboration of our LEGENDary team. Here's to another year of growth and achievements #CompanyCulture #WeAreLegend"  
[X Link](https://x.com/LegendBiotech/status/1882058135235711270)  2025-01-22T13:30Z [----] followers, [---] engagements


"On #WorldCancerDay we recognize the strength and resilience of those impacted by cancer. We are inspired by their courage and committed to putting people at the center of care by pushing the boundaries of #celltherapy to bring hope and healing to more patients. #UnitedbyUnique"  
[X Link](https://x.com/LegendBiotech/status/1886769177568174245)  2025-02-04T13:30Z [----] followers, [---] engagements


"On the eve of #InternationalDayofWomenandGirlsinScience we honor the brilliant women and girls shaping the future of science and medicine and driving innovation. To future #WomenInScience: Your curiosity creativity and courage are vital to building a healthier brighter world"  
[X Link](https://x.com/LegendBiotech/status/1888943502119370800)  2025-02-10T13:30Z [----] followers, [---] engagements


"This week the Legend Biotech team is at #Tandem25 with @ASTCT & @CIBMTR. 📍 Swing by booth [---] to connect learn and discuss new data on our CAR T #celltherapy for #MultipleMyeloma"  
[X Link](https://x.com/LegendBiotech/status/1889306141475434751)  2025-02-11T13:31Z [----] followers, [---] engagements


"Legends Senior Vice President of Global Manufacturing and Supply Birk Vanderween discussed our approach to integrating new technologies into our commercial bioprocessing operations with @_CellandGene. Read the article here: #CART #CellTherapy https://bit.ly/3QEjhHf https://bit.ly/3QEjhHf"  
[X Link](https://x.com/LegendBiotech/status/1891842379969085864)  2025-02-18T13:29Z [----] followers, [---] engagements


"Every infusion of our transformative #CellTherapy represents a chance to improve the quality of life for a patient. See how Tony and his wife Marys #MultipleMyeloma journey turned uncertainty into hope. @PreventionMag: #Sponsored #MyelomaActionMonth https://bit.ly/43hAlKF https://bit.ly/43hAlKF"  
[X Link](https://x.com/LegendBiotech/status/1895104099026378900)  2025-02-27T13:30Z [----] followers, [---] engagements


"This #MultipleMyelomaMonth were saluting our patient advocacy partners To begin the @LLSusa just released a docuseries A Path of Hope and Healing where Maurice a #MultipleMyeloma patient shares how #CellTherapy transformed his life. #LLS https://bit.ly/4kban1m https://bit.ly/4kban1m"  
[X Link](https://x.com/LegendBiotech/status/1896931137848533325)  2025-03-04T14:30Z [----] followers, [---] engagements


"Tomorrow is #InternationalWomensDay. 🙌 Lets #AccelerateAction and recognize the incredible women making a difference in science including our team of talented and passionate women developing innovative #CellTherapies for patients with #Cancer. #IWD2025 #WomenInScience"  
[X Link](https://x.com/LegendBiotech/status/1898025850450461010)  2025-03-07T15:00Z [----] followers, [---] engagements


"Happy #MyelomaMonday This week were highlighting @IMFmyeloma a global leader in #Myeloma research education and patient support. The IMF is at the forefront of the fight against myeloma. Discover their impactful work: #MyelomaActionMonth https://www.myeloma.org/ https://www.myeloma.org/"  
[X Link](https://x.com/LegendBiotech/status/1899097915072606417)  2025-03-10T14:00Z [----] followers, [---] engagements


"It's #MyelomaMonday and we're celebrating the @theMMRF They are the largest nonprofit in the world solely focused on accelerating a cure to improve the lives of every #MultipleMyeloma patient. Explore their vital contributions: #MultipleMyelomaMonth https://themmrf.org/ https://themmrf.org/"  
[X Link](https://x.com/LegendBiotech/status/1901627080661496153)  2025-03-17T13:30Z [----] followers, [---] engagements


"For our final #MyelomaMonday we recognize @HealthTree whose innovative technology unites patients & researchers to accelerate #BloodCancer research. Visit https://healthtree.org https://healthtree.org"  
[X Link](https://x.com/LegendBiotech/status/1904163794101628928)  2025-03-24T13:30Z [----] followers, [---] engagements


"We hope to see you at the @Myeloma_Societys Immune Effector Cell Therapies in #MultipleMyeloma Workshop in Boston Legend is a proud sponsor of this gathering of the brightest minds advancing #ImmuneEffector #CellTherapies"  
[X Link](https://x.com/LegendBiotech/status/1905250959732727884)  2025-03-27T13:30Z [----] followers, [---] engagements


"In a recent @GENBio interview our Senior Director of CAR-T Operations Sarah Snykers discussed the case study she presented at the #CHIBioprocessingSummit Europe about expanding Legends #CARTCellTherapy footprint worldwide. Read more https://www.genengnews.com/topics/bioprocessing/preparation-is-the-key-to-successful-scaleup/ https://www.genengnews.com/topics/bioprocessing/preparation-is-the-key-to-successful-scaleup/"  
[X Link](https://x.com/LegendBiotech/status/1905287078650184153)  2025-03-27T15:53Z [----] followers, [---] engagements


"April 5th marked the first anniversary of our #CellTherapy receiving FDA approval for second line use in treating adult patients with relapsed/refractory #MultipleMyeloma. 🎉 Thank you to our partners patients and the multiple myeloma community for making this possible"  
[X Link](https://x.com/LegendBiotech/status/1909253356951871633)  2025-04-07T14:34Z [----] followers, [---] engagements


"#LegendNews: Today we are excited to share our annual #ESG Report highlighting our commitment to Environmental Social and Governance practices. Read the full report: https://legendbiotech.com/about/sustainability/ https://legendbiotech.com/about/sustainability/"  
[X Link](https://x.com/LegendBiotech/status/1912513081671819548)  2025-04-16T14:27Z [----] followers, [---] engagements


"#LegendNews: Multiple abstracts reporting new data evaluating Legends #CellTherapy for #MultipleMyeloma and its solid tumor pipeline programs will be presented at the [----] @ASCO Annual Meeting. #ASCO25 #CART"  
[X Link](https://x.com/LegendBiotech/status/1915058308190261343)  2025-04-23T15:00Z [----] followers, [---] engagements


"Its #OncologyNursingMonth and were celebrating the extraordinary oncology nurses on the front lines of patient care. We witness the crucial role these #HealthcareHeroes play in the fight against cancer; were honored to work alongside such dedicated professionals. #CancerCare"  
[X Link](https://x.com/LegendBiotech/status/1917970874742772178)  2025-05-01T15:54Z [----] followers, [---] engagements


"#LegendNews: Our state-of-the-art Tech Lane facility in Belgium has begun clinical production of our #CART #CellTherapy Here's to a future where more patients can benefit from the transformative potential of cell therapy 🚀"  
[X Link](https://x.com/LegendBiotech/status/1924819902742868179)  2025-05-20T13:30Z [----] followers, [---] engagements


"Our CEO Ying Huang spoke with @GENbio about our leadership in #CellTherapy for #MultipleMyeloma & how we're expanding access to CAR-T therapies. Learn more: #CART #CellTherapy https://www.genengnews.com/topics/cancer/car-t-cell-therapy-new-advances-move-on-past-setbacks/ https://www.genengnews.com/topics/cancer/car-t-cell-therapy-new-advances-move-on-past-setbacks/"  
[X Link](https://x.com/LegendBiotech/status/1925189847427281227)  2025-05-21T14:00Z [----] followers, [---] engagements


"Thats a wrap on @ASCO [----] ✅ At this years meeting we showcased new data on #CART #CellTherapy in relapsed/refractory #MultipleMyeloma and presented exciting progress in solid tumors. Thanks to the ASCO community for a productive and collaborative #ASCO2025"  
[X Link](https://x.com/LegendBiotech/status/1930615612314644937)  2025-06-05T13:20Z [----] followers, [---] engagements


"Our #LEGENDary team in Belgium recently took part in the Kom op tegen Kanker cycling challenge to raise support for vital #CancerResearch. 🚴♂ Over [--] days they pedaled with purpose to cycle [----] km. Congrats to the entire team #WeAreLegend #CyclingForACause"  
[X Link](https://x.com/LegendBiotech/status/1932468357837570228)  2025-06-10T16:02Z [----] followers, [---] engagements


"Our CEO Dr. Ying Huang met with @OncoDaily at the #ASCO2025 Annual Meeting to discuss the groundbreaking long-term CARTITUDE-1 data generated by our #CART #CellTherapy for #MultipleMyeloma. Watch the full clip: https://youtu.be/pwsSyv2d_xQsi=PyNMERgcaw-aFKVI https://youtu.be/pwsSyv2d_xQsi=PyNMERgcaw-aFKVI"  
[X Link](https://x.com/LegendBiotech/status/1934995939896291406)  2025-06-17T15:25Z [----] followers, [---] engagements


"At #NERDLand2025 our #LEGENDary team connected with future scientists through our CAR-T Showcase Experience & inspiring sessions on the Talent Stage. Our interactive installations shared insights into our work in #CellTherapy and bringing transformative science to patients"  
[X Link](https://x.com/LegendBiotech/status/1937159958656876913)  2025-06-23T14:44Z [----] followers, [---] engagements


"#CARTaccess news: The FDA has removed REMS requirements for BCMA- & CD19-targeted CAR-Ts. This pivotal milestone creates faster access and broader availability in community settings and makes CART more practical scalable & patient-centric"  
[X Link](https://x.com/LegendBiotech/status/1939673669825081797)  2025-06-30T13:13Z [----] followers, [---] engagements


"Today begins a new campaign to educate #MultipleMyeloma patients about our #CART #CellTherapy a single infusion thats helped thousandsmake #time4more. https://www.youtube.com/watchv=Elzbw2U5nVI https://www.youtube.com/watchv=Elzbw2U5nVI"  
[X Link](https://x.com/LegendBiotech/status/1950609349434335437)  2025-07-30T17:28Z [----] followers, [--] engagements


"In honor of #NationalInternDay we're proud to celebrate the talented university students who joined us this summer Our interns explored the various facets of our business engaging in weekly Lunch & Learn sessions with teams across the company and gaining valuable insights"  
[X Link](https://x.com/LegendBiotech/status/1950911831280648680)  2025-07-31T13:30Z [----] followers, [---] engagements


"Lung cancer is one of the toughest cancers to treat and patients need innovative treatment options. This #WorldLungCancerDay we reaffirm our commitment to advancing #CellTherapies that bring hope to those facing difficult-to-treat cancers like #LungCancer"  
[X Link](https://x.com/LegendBiotech/status/1951312973747613742)  2025-08-01T16:04Z [----] followers, [--] engagements


"This #BloodCancerAwareness Month we stand with patients and families as we advance #CART #CellTherapies that have the potential to transform care and bring hope to those impacted by #Cancer. #MakeBloodCancerVisible"  
[X Link](https://x.com/LegendBiotech/status/1962870627959714160)  2025-09-02T13:30Z [----] followers, [---] engagements


"Heading to Barcelona for the @IASLC #WCLC25 Well be presenting data on our #CART #CellTherapy in #SCLC in two sessions on Sept. [--]. Learn more about our #SCLC presentations: Hope to see you there https://wclc.iaslc.org/ https://wclc.iaslc.org/"  
[X Link](https://x.com/LegendBiotech/status/1963595404051644610)  2025-09-04T13:30Z [----] followers, [---] engagements


"Our CEO Ying Huang takes the stage in a fireside chat @MorganStanley Global Healthcare Conference in NYC tomorrow at 4:05 p.m. ET. Register: https://investors.legendbiotech.com/events-and-presentations https://investors.legendbiotech.com/events-and-presentations"  
[X Link](https://x.com/LegendBiotech/status/1965044954235076979)  2025-09-08T13:30Z [----] followers, [---] engagements


"Were excited to be at @GBXEvents #CGTI2025 in Barcelona Tomorrow at 2:30 P.M. CEST Frederik Buysse GM & VP Europe will share how Legend built and operationalized its Ghent Belgium #CART #CellTherapy manufacturing site and our broader efforts to advance CAR-T worldwide"  
[X Link](https://x.com/LegendBiotech/status/1965769730712875438)  2025-09-10T13:30Z [----] followers, [--] engagements


"#BloodCancerAwareness Month is a reminder of the vital role research plays in improving patient outcomes. Legend is advancing #CART #CellTherapies driven by innovation & hope for patients with limited options to realize a future where #BloodCancers are no longer life-limiting"  
[X Link](https://x.com/LegendBiotech/status/1966494507131638096)  2025-09-12T13:30Z [----] followers, [---] engagements


"Were thrilled to be at the @Myeloma_Society Annual Meeting in Toronto Stop by booth #427 to meet our team & learn about our portfolio of #CellTherapies. Hope to see you at #IMS25 #Toronto2025"  
[X Link](https://x.com/LegendBiotech/status/1968306447697199211)  2025-09-17T13:30Z [----] followers, [---] engagements


"An updated CARTITUDE-4 analysis published in @TheLancetOncol reports outcomes evaluating earlier use of our #CART #CellTherapy for #MultipleMyeloma adding to the growing clinical evidence informing treatment decisions and future research. 🔗 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00653-9/fulltext https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00653-9/fulltext"  
[X Link](https://x.com/anyuser/status/2011438153320525994)  2026-01-14T14:00Z [----] followers, [---] engagements


"#LegendNews: Legend Biotech will host a webcast to announce [----] fourth-quarter financial results on March [--] at [--] a.m. ET. Register to join here: $LEGN https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-conference-call-fourth-quarter-0 https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-conference-call-fourth-quarter-0"  
[X Link](https://x.com/LegendBiotech/status/1894373439529451956)  2025-02-25T13:06Z [----] followers, [---] engagements


"#LegendNews: Today we released our [----] Q4 and Full-Year financial results. Our Interim Chief Financial Officer Jessie Yeung shares her thoughts. Read the highlights here: #WeAreLegend #FinancialResults $LEGN https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-fourth-quarter-and-full-year-2024-results https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-fourth-quarter-and-full-year-2024-results"  
[X Link](https://x.com/LegendBiotech/status/1899415965869228332)  2025-03-11T11:03Z [----] followers, [---] engagements


"This week were in Boston for the CAR-TCR Summit [----] 🕐 9/24 8:20 am: Fireside Chat w/ Mythili Koneru 🕐 9/24 5:30 pm: Claudin [----] & DLL3 Targeted CAR-T Cells for GC & SCLC 🕐 9/25 1:45 pm: Advancing cell therapy w/ Ben Oshrine Driving the future of #CART #CellTherapies"  
[X Link](https://x.com/LegendBiotech/status/1970118383183294929)  2025-09-22T13:30Z [----] followers, [---] engagements


"Behind every patient with #BloodCancer are caregivers families & friends who provide strength & support. This #BloodCancerAwareness Month we honor their vital role in helping patients navigate their journeys with resilience & compassion. #MakeBloodCancerVisible #KnowMyeloma"  
[X Link](https://x.com/LegendBiotech/status/1970480772130775417)  2025-09-23T13:30Z [----] followers, [--] engagements


"#LegendNews: Legend was honored as the Foreign Investor of the Year by @FIT_agency We were proud to celebrate with the local #LifeSciences community and be recognized for our continued growth and investment in Ghent. 🔗 #Biotech #CellTherapy https://www.globenewswire.com/news-release/2025/11/27/3195718/0/en/Legend-Biotech-Awarded-2025-FIBA-Foreign-Investor-of-the-Year-by-Flanders-Investment-Trade.html https://www.globenewswire.com/news-release/2025/11/27/3195718/0/en/Legend-Biotech-Awarded-2025-FIBA-Foreign-Investor-of-the-Year-by-Flanders-Investment-Trade.html"  
[X Link](https://x.com/LegendBiotech/status/1995550117361807509)  2025-12-01T17:46Z [----] followers, [--] engagements


"Attending the Cell Therapy for Autoimmune Disease Summit in Philly Today [--] PM ET Chris Tehlirian Legend's Executive Medical Director will share how collaborative #Innovation & smart regulatory strategy can accelerate global #CellTherapy development. https://cell-therapy-autoimmune-disease.com/seminar/navigating-iit-ema-regulatory-pathways-to-accelerate-cell-therapy-global-development/ https://cell-therapy-autoimmune-disease.com/seminar/navigating-iit-ema-regulatory-pathways-to-accelerate-cell-therapy-global-development/"  
[X Link](https://x.com/LegendBiotech/status/1995858491345653951)  2025-12-02T14:12Z [----] followers, [--] engagements


"#LegendNews: Legend Biotech will host a webcast to announce [----] first-quarter financial results on May [--] at [--] a.m. ET. Register to join here: $LEGN #WeAreLegend #FinancialResults https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-conference-call-first-quarter-2025 https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-conference-call-first-quarter-2025"  
[X Link](https://x.com/LegendBiotech/status/1917195306367701227)  2025-04-29T12:32Z [----] followers, [---] engagements


"#LegendNews: Today we shared our [----] first-quarter financial results with insights from our CEO Ying Huang. Read the highlights and more here: #CellTherapy #CART https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-first-quarter-2025-results-and-recent https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-first-quarter-2025-results-and-recent"  
[X Link](https://x.com/LegendBiotech/status/1922246285416911091)  2025-05-13T11:03Z [----] followers, [---] engagements


"This past weekend our #LEGENDary team laced up their sneakers to take part in the @IMFmyeloma #MiraclesforMyeloma 5K in NJ It was an inspiring day of connection and purpose and were grateful to take part in striding toward a cure for #MultipleMyeloma"  
[X Link](https://x.com/LegendBiotech/status/1968013562712035480)  2025-09-16T18:06Z [----] followers, [---] engagements


"We are thrilled to announce Legend Biotech is an official partner of @NerdlandBe Festival [----] 🔬We can't wait to connect with fellow #Science enthusiasts families and the vibrant #Nerdland community. Check out our lineup of Legendary speakers: https://legendbiotech.eu/nerdlandfestival2025/ https://legendbiotech.eu/nerdlandfestival2025/"  
[X Link](https://x.com/LegendBiotech/status/1919419082736050470)  2025-05-05T15:49Z [----] followers, [---] engagements


"Today is #WorldBloodCancerDay. At Legend Biotech we stand in solidarity with patients families and healthcare professionals impacted by blood cancers like #MultipleMyeloma. We are committed to advancing transformative therapies that improve patient outcomes. #CellTherapy"  
[X Link](https://x.com/LegendBiotech/status/1927719003444670632)  2025-05-28T13:30Z [----] followers, [---] engagements


"The @ASCO Annual Meeting begins today Our CEO Ying Huang shares his thoughts on the upcoming conference and previews the abstracts we will present regarding our #CART #CellTherapy for #MultipleMyeloma. If youre attending visit us at booth #11113. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-announces-new-oncologic-hematologic-therapeutic https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-announces-new-oncologic-hematologic-therapeutic"  
[X Link](https://x.com/LegendBiotech/status/1928066040132497803)  2025-05-29T12:29Z [----] followers, [---] engagements


"#LegendNews: Today we shared our [----] second-quarter financial results with insights from our CEO Ying Huang. Read the highlights and more: #CellTherapy #CART https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-second-quarter-2025-results-and-recent https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-reports-second-quarter-2025-results-and-recent"  
[X Link](https://x.com/LegendBiotech/status/1954860967902236948)  2025-08-11T11:02Z [----] followers, [---] engagements


"Last week the Legend Biotech team attended #SOHO2025 in Houston Inspired by the cutting-edge presentations shaping the future of #CancerCare a powerful reminder of how innovation can transform patients lives"  
[X Link](https://x.com/LegendBiotech/status/1965415069162041575)  2025-09-09T14:00Z [----] followers, [---] engagements


"Our time at #Tandem26 highlighted the transformative progress in the #MultipleMyeloma landscape and the need to advance evidence-based treatment through clinical research and real-world insights. Ongoing scientific exchange with the #hematology community remains essential"  
[X Link](https://x.com/LegendBiotech/status/2021230173417284035)  2026-02-10T14:30Z [----] followers, [--] engagements


"Our time at #Tandem26 highlighted the transformative progress in the #MultipleMyeloma landscape and the need to advance evidence-based treatment through clinical research and real-world insights. Ongoing scientific exchange with the #hematology community remains essential"  
[X Link](https://x.com/LegendBiotech/status/2021231830288986524)  2026-02-10T14:36Z [----] followers, [--] engagements


"We are thrilled to announce that our #CART #CellTherapy for patients with #MultipleMyeloma has achieved a record-high manufacturing success rate of 97% at our facility in Raritan NJ. At Legend Biotech we push beyond boundaries every day to advance our transformational therapy"  
[X Link](https://x.com/LegendBiotech/status/1923007963603795980)  2025-05-15T13:30Z [----] followers, [---] engagements


"#LegendNews: Join us Sunday June [--] [--] p.m. CT (7 p.m. ET) at @ASCO Annual Meeting for Legend Biotechs Investor Event in Chicago. Hear the latest on our clinical progress and #CellTherapy pipeline. #ASCO25 #Investors #Biotech #CART $LEGN https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-event-during-2025-american-society https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-event-during-2025-american-society"  
[X Link](https://x.com/LegendBiotech/status/1924437308066955628)  2025-05-19T12:09Z [----] followers, [---] engagements


"We will present long-term data on our #CART therapy for multiple myeloma at @ASCO and new data at @EHA_Hematology. Visit our ASCO exhibit #11113 to learn about our transformative therapy that has treated 6K patients to date and our work in #SolidTumors. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-announces-new-oncologic-hematologic-therapeutic https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-announces-new-oncologic-hematologic-therapeutic"  
[X Link](https://x.com/LegendBiotech/status/1925681734265229690)  2025-05-22T22:34Z [----] followers, [---] engagements


"#SavetheDate June [--] is #NationalCancerSurvivorsDay. 🌟 At Legend Biotech we honor the strength and resilience of cancer survivors. Their journeys inspire our commitment to advancing #CellTherapies for a brighter future and long-term survival. #PatientImpact #CART #CellTherapy"  
[X Link](https://x.com/LegendBiotech/status/1928443781835350224)  2025-05-30T13:30Z [----] followers, [---] engagements


"#ICYMI: Our CEO Dr. Ying Huang met with @BiotechTV at #ASCO25 to discuss new long-term OS data from our #CART #CellTherapy trials to treat #MultipleMyeloma expanding pipeline for #SolidTumors and more. Watch now: #OncologyInnovation https://bit.ly/3ZMsWjD https://bit.ly/3ZMsWjD"  
[X Link](https://x.com/LegendBiotech/status/1929634984408621521)  2025-06-02T20:23Z [----] followers, [---] engagements


"@ASCO [----] updates: Groundbreaking long-term (5 year) results from the CARTITUDE-1 trial in patients with RRMM. ➡CARTITUDE-4: PFS/OS results in patients with RRMM including high-risk pts. ➡ LB2102 & LB1098: encouraging preliminary results. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-unveils-groundbreaking-5-year-survival-data https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-unveils-groundbreaking-5-year-survival-data"  
[X Link](https://x.com/LegendBiotech/status/1929913334809202850)  2025-06-03T14:49Z [----] followers, [---] engagements


"Legend Biotech is at the @EHA_Hematology [----] Congress Join us June [--] [----] 17:00-18:15 CEST for an encore oral presentation of our groundbreaking five-year survival data for our #CART #CellTherapy in relapsed/refractory #MultipleMyeloma"  
[X Link](https://x.com/LegendBiotech/status/1933154824213963123)  2025-06-12T13:30Z [----] followers, [---] engagements


"#LegendNews: Legend Biotech will host a webcast to share [----] second-quarter financial results on August [--] at [--] a.m. ET. Register to join here: $LEGN #CART #CellTherapy https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-conference-call-second-quarter-2025 https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-host-investor-conference-call-second-quarter-2025"  
[X Link](https://x.com/LegendBiotech/status/1949804535318241602)  2025-07-28T12:10Z [----] followers, [---] engagements


"Headed to the @MorganStanley Global Healthcare Conference Dont miss our CEO Ying Huang as he joins a fireside chat on September [--] at 4:05 p.m. ET. 🔗Learn more and register: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-participate-morgan-stanley-global-healthcare https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-participate-morgan-stanley-global-healthcare"  
[X Link](https://x.com/LegendBiotech/status/1960312527935476125)  2025-08-26T12:05Z [----] followers, [---] engagements


"Legends CEO @YingHuang shares how Legend and J&J are rapidly scaling #CellTherapy. Our cell therapy delivered $524M last quarter (+84% YoY) the highest for any CAR-T to date. We remain focused on profitability in [----]. #CART #CancerResearch https://schwabnetwork.com/video/legend-biotech-ceo-legn-on-jnj-partnership-rapidly-scaling-cancer-drug-revenue https://schwabnetwork.com/video/legend-biotech-ceo-legn-on-jnj-partnership-rapidly-scaling-cancer-drug-revenue"  
[X Link](https://x.com/anyuser/status/1998838641670402298)  2025-12-10T19:34Z [----] followers, [---] engagements


"#ICYMI: At #ASH2025 CEO Ying Huang spoke with @BradLoncar of @BiotechTV about the impact of #CART #CellTherapy and whats ahead for Legends pipeline. Long-term data show [--] mo PFS in some patient groups. Watch: https://www.biotechtv.com/post/legend-biotech-ash-2025 https://www.biotechtv.com/post/legend-biotech-ash-2025"  
[X Link](https://x.com/anyuser/status/1999494458992124285)  2025-12-12T15:00Z [----] followers, [---] engagements


"Proud to see our CAR-T cell therapy included in @PopScis Best of Whats New [----] highlighting innovations shaping the future of medicine. Grateful to our teams partners and the patients who inspire this work. https://www.popsci.com/gear/best-of-whats-new-2025/ https://www.popsci.com/gear/best-of-whats-new-2025/"  
[X Link](https://x.com/anyuser/status/2000610255290446275)  2025-12-15T16:53Z [----] followers, [---] engagements


"The countdown to #JPM26 is on Join our CEO Ying Huang on Jan. [--] @ [--] a.m. PT for updates on our #CellTherapy programs clinical progress & global growth initiatives as we advance transformative #CellTherapies to patients worldwide. More: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-44th-annual-jp-morgan-healthcare https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-44th-annual-jp-morgan-healthcare"  
[X Link](https://x.com/anyuser/status/2001280208045752732)  2025-12-17T13:15Z [----] followers, [---] engagements


"During this holiday season were reflecting on what drives us the people behind our progress and the patients who inspire us every day. Grateful for our #LEGENDary colleagues partners & collaborators around the world"  
[X Link](https://x.com/anyuser/status/2003559610498883748)  2025-12-23T20:13Z [----] followers, [---] engagements


"As we close out the year were proud of the progress made across our science our manufacturing network and our global teams. Our CEO Ying Huang shares his thoughts. #WeAreLegend"  
[X Link](https://x.com/anyuser/status/2005647496115310996)  2025-12-29T14:30Z [----] followers, [---] engagements


"Phase [--] data in advanced gastroesophageal adenocarcinoma will be presented on Jan. [--] 11:30 a.m. 1:00 p.m. PST (Abstract [---] Poster D5). https://meetings.asco.org/meetings/2026-asco-gastrointestinal-cancers-symposium/333/program-guide/scheduled-sessions/searchq=lb1908 https://meetings.asco.org/meetings/2026-asco-gastrointestinal-cancers-symposium/333/program-guide/scheduled-sessions/searchq=lb1908"  
[X Link](https://x.com/anyuser/status/2008973086910263780)  2026-01-07T18:44Z [----] followers, [---] engagements


"Next week well be on site at #JPM26 Our CEO Ying Huang will present on Jan. [--] @ [--] a.m. PT sharing updates on our #Innovative pipeline and expanding global footprint in #CellTherapy. More: https://investors.legendbiotech.com/events-and-presentations https://investors.legendbiotech.com/events-and-presentations"  
[X Link](https://x.com/anyuser/status/2009319749826826565)  2026-01-08T17:42Z [----] followers, [---] engagements


"#LegendNews: We have treated more than [-----] patients worldwide with our #CART #CellTherapy since its approval. This milestone reflects the dedication of our teams advancing care for #MultipleMyeloma. #PatientsFirst https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-recent-business-updates-44th-annual-jp https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-recent-business-updates-44th-annual-jp"  
[X Link](https://x.com/anyuser/status/2010804784492933620)  2026-01-12T20:03Z [----] followers, [---] engagements


"We will present data on our #CART #CellTherapy for #MultipleMyeloma at #Tandem26 Meetings of @ASTCT and @CIBMTR in Salt Lake City. Six posters will highlight efficacy safety and real-world outcomes supporting earlier use in the treatment journey. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"  
[X Link](https://x.com/anyuser/status/2013963149079105818)  2026-01-21T13:13Z [----] followers, [---] engagements


"In a @SocietyofHemOnc Insider article our CEO Ying Huang discusses the evolution of our #CART #CellTherapy from the first treated patient with #MultipleMyeloma through global collaboration and long-term follow-up. 🔗 Read more: #CART #CancerResearch https://sohoinsider.com/news/treatment-successes-inspire-some-to-declare-myeloma-curable/ https://sohoinsider.com/news/treatment-successes-inspire-some-to-declare-myeloma-curable/"  
[X Link](https://x.com/anyuser/status/2014353179891093869)  2026-01-22T15:03Z [----] followers, [---] engagements


"#WorldCancerDay reminds us why we do what we do: supporting patients caregivers and communities impacted by cancer while advancing innovative therapies. #PatientsFirst always. We are #UnitedByUnique"  
[X Link](https://x.com/anyuser/status/2019055847276531895)  2026-02-04T14:30Z [----] followers, [---] engagements


"At the #Tandem26 of @ASTCT and @CIBMTR were sharing data that reinforces growing evidence which supports earlier use of our #CART #CellTherapy in #MultipleMyeloma. 📷 Read more: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"  
[X Link](https://x.com/anyuser/status/2019418232663470237)  2026-02-05T14:30Z [----] followers, [---] engagements


"Our VP & Head of Early-Stage Drug Dev Dong Geng will participate in a panel on in vivo cell therapy Feb. [--] @ 1:20 p.m. at #IO360Summit. 📍 Track 2: Cell Therapy Plenary 🎤 In Vivo Cell Therapy: Rewriting the Rules of Cell-Based Treatment https://io360summit.com/ https://io360summit.com/"  
[X Link](https://x.com/anyuser/status/2020869819197739063)  2026-02-09T14:38Z [----] followers, [---] engagements


"Our time at #Tandem26 highlighted the transformative progress in #MultipleMyeloma landscape treatment and the need to advance evidence-based through clinical research and real-world insights. Ongoing scientific exchange with the #hematology community remains essential"  
[X Link](https://x.com/anyuser/status/2021243741122539955)  2026-02-10T15:23Z [----] followers, [---] engagements


"Today we celebrate the remarkable women driving scientific progress at Legend and support the next generation of innovators by fostering curiosity inclusion and opportunity for future women in #Science. #InternationalDayOfWomenAndGirlsInScience"  
[X Link](https://x.com/anyuser/status/2021592563421954109)  2026-02-11T14:30Z [----] followers, [--] engagements


"Today we celebrate the remarkable women driving scientific progress at Legend and support the next generation of innovators by fostering curiosity inclusion and opportunity for future women in #Science. #InternationalDayOfWomenAndGirlsInScience"  
[X Link](https://x.com/anyuser/status/2021592563421954109)  2026-02-11T14:30Z [----] followers, [--] engagements


"Our time at #Tandem26 highlighted the transformative progress in #MultipleMyeloma landscape treatment and the need to advance evidence-based through clinical research and real-world insights. Ongoing scientific exchange with the #hematology community remains essential"  
[X Link](https://x.com/anyuser/status/2021243741122539955)  2026-02-10T15:23Z [----] followers, [---] engagements


"Our VP & Head of Early-Stage Drug Dev Dong Geng will participate in a panel on in vivo cell therapy Feb. [--] @ 1:20 p.m. at #IO360Summit. 📍 Track 2: Cell Therapy Plenary 🎤 In Vivo Cell Therapy: Rewriting the Rules of Cell-Based Treatment https://io360summit.com/ https://io360summit.com/"  
[X Link](https://x.com/anyuser/status/2020869819197739063)  2026-02-09T14:38Z [----] followers, [---] engagements


"At the #Tandem26 of @ASTCT and @CIBMTR were sharing data that reinforces growing evidence which supports earlier use of our #CART #CellTherapy in #MultipleMyeloma. 📷 Read more: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"  
[X Link](https://x.com/anyuser/status/2019418232663470237)  2026-02-05T14:30Z [----] followers, [---] engagements


"#WorldCancerDay reminds us why we do what we do: supporting patients caregivers and communities impacted by cancer while advancing innovative therapies. #PatientsFirst always. We are #UnitedByUnique"  
[X Link](https://x.com/anyuser/status/2019055847276531895)  2026-02-04T14:30Z [----] followers, [---] engagements


"RT @LegendUSMA: Excited for the #TANDEM26 Annual Meeting and the chance to advance patient-centered innovation together. We hope you will c"  
[X Link](https://x.com/anyuser/status/2019051853271486752)  2026-02-04T14:14Z [----] followers, [--] engagements


"Excited for the #TANDEM26 Annual Meeting and the chance to advance patient-centered innovation together. We hope you will connect with our Medical Affairs team at Booth #301 for those attending live in Salt Lake City. For more on our science: #mmsm #CART https://bit.ly/4sZ9Wvy https://bit.ly/4sZ9Wvy"  
[X Link](https://x.com/anyuser/status/2018775638073581921)  2026-02-03T19:56Z [---] followers, [---] engagements


"In a @SocietyofHemOnc Insider article our CEO Ying Huang discusses the evolution of our #CART #CellTherapy from the first treated patient with #MultipleMyeloma through global collaboration and long-term follow-up. 🔗 Read more: #CART #CancerResearch https://sohoinsider.com/news/treatment-successes-inspire-some-to-declare-myeloma-curable/ https://sohoinsider.com/news/treatment-successes-inspire-some-to-declare-myeloma-curable/"  
[X Link](https://x.com/anyuser/status/2014353179891093869)  2026-01-22T15:03Z [----] followers, [---] engagements


"We will present data on our #CART #CellTherapy for #MultipleMyeloma at #Tandem26 Meetings of @ASTCT and @CIBMTR in Salt Lake City. Six posters will highlight efficacy safety and real-world outcomes supporting earlier use in the treatment journey. https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"  
[X Link](https://x.com/anyuser/status/2013963149079105818)  2026-01-21T13:13Z [----] followers, [---] engagements


"An updated CARTITUDE-4 analysis published in @TheLancetOncol reports outcomes evaluating earlier use of our #CART #CellTherapy for #MultipleMyeloma adding to the growing clinical evidence informing treatment decisions and future research. 🔗 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00653-9/fulltext https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00653-9/fulltext"  
[X Link](https://x.com/anyuser/status/2011438153320525994)  2026-01-14T14:00Z [----] followers, [---] engagements


"#LegendNews: We have treated more than [-----] patients worldwide with our #CART #CellTherapy since its approval. This milestone reflects the dedication of our teams advancing care for #MultipleMyeloma. #PatientsFirst https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-recent-business-updates-44th-annual-jp https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-recent-business-updates-44th-annual-jp"  
[X Link](https://x.com/anyuser/status/2010804784492933620)  2026-01-12T20:03Z [----] followers, [---] engagements


"Next week well be on site at #JPM26 Our CEO Ying Huang will present on Jan. [--] @ [--] a.m. PT sharing updates on our #Innovative pipeline and expanding global footprint in #CellTherapy. More: https://investors.legendbiotech.com/events-and-presentations https://investors.legendbiotech.com/events-and-presentations"  
[X Link](https://x.com/anyuser/status/2009319749826826565)  2026-01-08T17:42Z [----] followers, [---] engagements


"Phase [--] data in advanced gastroesophageal adenocarcinoma will be presented on Jan. [--] 11:30 a.m. 1:00 p.m. PST (Abstract [---] Poster D5). https://meetings.asco.org/meetings/2026-asco-gastrointestinal-cancers-symposium/333/program-guide/scheduled-sessions/searchq=lb1908 https://meetings.asco.org/meetings/2026-asco-gastrointestinal-cancers-symposium/333/program-guide/scheduled-sessions/searchq=lb1908"  
[X Link](https://x.com/anyuser/status/2008973086910263780)  2026-01-07T18:44Z [----] followers, [---] engagements


"As we close out the year were proud of the progress made across our science our manufacturing network and our global teams. Our CEO Ying Huang shares his thoughts. #WeAreLegend"  
[X Link](https://x.com/anyuser/status/2005647496115310996)  2025-12-29T14:30Z [----] followers, [---] engagements


"During this holiday season were reflecting on what drives us the people behind our progress and the patients who inspire us every day. Grateful for our #LEGENDary colleagues partners & collaborators around the world"  
[X Link](https://x.com/anyuser/status/2003559610498883748)  2025-12-23T20:13Z [----] followers, [---] engagements


"The countdown to #JPM26 is on Join our CEO Ying Huang on Jan. [--] @ [--] a.m. PT for updates on our #CellTherapy programs clinical progress & global growth initiatives as we advance transformative #CellTherapies to patients worldwide. More: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-44th-annual-jp-morgan-healthcare https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-44th-annual-jp-morgan-healthcare"  
[X Link](https://x.com/anyuser/status/2001280208045752732)  2025-12-17T13:15Z [----] followers, [---] engagements


"Proud to see our CAR-T cell therapy included in @PopScis Best of Whats New [----] highlighting innovations shaping the future of medicine. Grateful to our teams partners and the patients who inspire this work. https://www.popsci.com/gear/best-of-whats-new-2025/ https://www.popsci.com/gear/best-of-whats-new-2025/"  
[X Link](https://x.com/anyuser/status/2000610255290446275)  2025-12-15T16:53Z [----] followers, [---] engagements


"#ICYMI: At #ASH2025 CEO Ying Huang spoke with @BradLoncar of @BiotechTV about the impact of #CART #CellTherapy and whats ahead for Legends pipeline. Long-term data show [--] mo PFS in some patient groups. Watch: https://www.biotechtv.com/post/legend-biotech-ash-2025 https://www.biotechtv.com/post/legend-biotech-ash-2025"  
[X Link](https://x.com/anyuser/status/1999494458992124285)  2025-12-12T15:00Z [----] followers, [---] engagements


"Legends CEO @YingHuang shares how Legend and J&J are rapidly scaling #CellTherapy. Our cell therapy delivered $524M last quarter (+84% YoY) the highest for any CAR-T to date. We remain focused on profitability in [----]. #CART #CancerResearch https://schwabnetwork.com/video/legend-biotech-ceo-legn-on-jnj-partnership-rapidly-scaling-cancer-drug-revenue https://schwabnetwork.com/video/legend-biotech-ceo-legn-on-jnj-partnership-rapidly-scaling-cancer-drug-revenue"  
[X Link](https://x.com/anyuser/status/1998838641670402298)  2025-12-10T19:34Z [----] followers, [---] engagements


"Thats a wrap on #ASH25 Highlights from Legend: - Landmark 50.4-month median PFS data in #MultipleMyeloma patients - New translational insights on earlier #CellTherapy use - First-in-human data from our #Allogeneic platform in #NonHodgkinsLymphoma Recap: https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-new-carvyktir-data-multiple-myeloma https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-new-carvyktir-data-multiple-myeloma"  
[X Link](https://x.com/anyuser/status/1998429354909720676)  2025-12-09T16:27Z [----] followers, [---] engagements


"#LegendNews: New data presented at #ASH25 highlight durable outcomes with our #CART #CellTherapy in #MultipleMyeloma along with #Immune insights real-world results and first-in-human data from our #Allogeneic CAR-T in #NonHodgkinsLymphoma. 🔗 https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-new-carvyktir-data-multiple-myeloma https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-highlights-new-carvyktir-data-multiple-myeloma"  
[X Link](https://x.com/anyuser/status/1997385151563681840)  2025-12-06T19:18Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing